BURNABY, British Columbia (AP) _ Xenon Pharmaceuticals Inc. (XENE) on Tuesday reported a loss of $7.7 million in its third quarter.
The Burnaby, British Columbia-based company said it had a loss of 43 cents per share.
The gene therapy biotech company posted revenue of $264,000 in the period.
In the final minutes of trading on Tuesday, the company's shares hit $3.15. A year ago, they were trading at $7.50.